Pfizer Inc, Baxter and B.Braun Melsungen AG are Dominating the U.S. Sodium Lactate Market for Pharmaceutical Industries in 2020

U.S. Sodium Lactate Market for pharmaceutical industries is expected to grow with the CAGR of 12.2% in the forecast period of 2021 to 2028. The years considered for study are as mentioned below.

Access Full Report @ https://www.databridgemarketresearch.com/reports/us-sodium-lactate-market

U.S. sodium lactate market for pharmaceutical industries is a highly consolidated market, which includes specific number of key players. The market has witnessed increased production capacities owing to favourable market scenario.   

The major players dealing in the U.S. sodium lactate market for pharmaceutical industries are introducing are expanding their production capacities, launching new companies, and adopting strategic initiative such as acquisition, agreement, business expansion, award and recognition into the market. This helped companies to maximize the sales with enhanced product portfolio.

For instance:

  • In March 2021, Corbion announced that the company has decided to boost the lactic acid production capacity through a series of concurrent expansion projects. This will increase the market for Corbion and will add up revenue of the company in the forecasted period.

Pfizer Inc. is the dominating player in the U.S. sodium lactate market for pharmaceutical industries. The other key players existing in the market includes AdvaCare Pharma, Viatris Inc, Corbion, Baxter, DR. Paul Lehmann GMBH & CO.KGAA, B.Braun Melsungen AG.

U.S. Sodium Lactate Market for Pharmaceutical IndustriesPfizer Inc.

Pfizer Inc. headquarters in New York, USA, mainly focuses on producing standard for quality, safety and value in the discovery, development, and manufacturing of healthcare products involving innovative medicines and vaccines. Pfizer deals in three business segments- Biopharmaceuticals, Consumer health & Upjohn.

  • In July 2019, Pfizer Inc announced its acquisition completion of array biopharma. The company strengthen biopharmaceutical business advancing breakthrough science to discover, develop, and commercialize targeted small molecules into medicines. The step helped to accelerate Pfizer’s long term growth through new medicines.

The company has wide presence across Americas, Asia, Europe, Middle East and Africa. The company also has various subsidiary companies such as Hospira (Illnois, U.S), Array Biopharm (U.S), Meridian Medical Technologies Inc (Maryland, U.S), Pfizer Canada Inc (Kirkland, Canada), among others.

Baxter

Baxter headquartered in Illinois, U.S. was founded in 1931. The company focuses is engaged in offering products for domains such as acute and chronic dialysis therapies, sterile IV solutions, infusion system & devices, parenteral nutritional therapies, inhaled anaesthetics, generic injectable pharmaceuticals and surgical haemostat & sealant products.

  • In March 2021, Baxter announced that they had started an awareness program for kidney dialysis and peritoneal dialysis, which used sodium lactate as a dialysis solution, increasing the demand for their product in the forecasted period.

The company has wide presence across Americas, Asia, Europe, Middle East and Africa. The company also have various subsidiary companies such as Baxter Healthcare Pvt Ltd (Australia), Baxter SA (Belgium), Baxter Corporation (Canada), Baxter Deutschland GMBH (Germany), among others.

B.Braun Melsungen AG

B.Braun Melsungen AG, headquartered in Melsungen, Germany. Was founded in 1893.The company focuses on production and marketing of systems for anaesthetics, intensive care, cardiology, and surgery, among others. The company functions in various business segments such as Hospital Care, Aesculap, Out- patient market, and B.Braun Avitum.

  • In May 2019, B.Braun Melsungen AG announced that they have invested USD 100 Million in new and enhanced IV therapy manufacturing facilities to help ensure a reliable and consistent supply of vital IV fluids that American health care providers need every day. This will help the company unmet demand for sodium lactate types I.V fluids and contribute in company’s revenue.  

The company has wide presence across Americas, Asia, Europe, Middle East and Africa. The company also have various subsidiary companies such as B.Braun Medical Pvt Ltd (South Africa), B.Braun Medical Gulf Kenya Ltd (Kenya), B.Braun Singapore Pvt Ltd (Singapore), among others.